Mandarake Inc.
Mandarake Inc. (2652.T) Financial Performance & Income Statement Overview
Analyze Mandarake Inc. (2652.T) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Mandarake Inc. (2652.T) Income Statement & Financial Overview
Review Mandarake Inc. 2652.T income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $3.76B | $3.61B | $3.62B | $3.68B |
| Cost of Revenue | $1.78B | $1.66B | $1.69B | $1.70B |
| Gross Profit | $1.99B | $1.95B | $1.93B | $1.97B |
| Gross Profit Ratio | $0.53 | $0.54 | $0.53 | $0.54 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.67B | $1.59B | $1.41B | $0.00 |
| Operating Expenses | $1.67B | $1.59B | $1.41B | $1.35B |
| Total Costs & Expenses | -$3.44B | -$3.25B | $3.10B | $3.05B |
| Interest Income | $52000.00 | $92000.00 | $9000.00 | $5000.00 |
| Interest Expense | $9.009M | $9.16M | $9.08M | $9.23M |
| Depreciation & Amortization | $56.84M | $60.97M | $60.88M | $894000.00 |
| EBITDA | $375.32M | $425.46M | $585.97M | $626.89M |
| EBITDA Ratio | $0.10 | $0.12 | $0.16 | $0.17 |
| Operating Income | $320.30M | $358.83M | $521.65M | $626.00M |
| Operating Income Ratio | $0.09 | $0.10 | $0.14 | $0.17 |
| Other Income/Expenses (Net) | -$10.84M | -$3.50M | -$5.64M | -$8.33M |
| Income Before Tax | $309.47M | $355.32M | $516.005M | $617.66M |
| Income Before Tax Ratio | $0.08 | $0.10 | $0.14 | $0.17 |
| Income Tax Expense | $164.01M | $129.39M | $165.57M | $198.16M |
| Net Income | $145.45M | $225.93M | $350.43M | $419.50M |
| Net Income Ratio | $0.04 | $0.06 | $0.10 | $0.11 |
| EPS | $4.42 | $6.87 | $10.62 | $12.71 |
| Diluted EPS | $4.42 | $6.87 | $10.62 | $12.71 |
| Weighted Avg Shares Outstanding | $32.87M | $32.87M | $33.006M | $33.006M |
| Weighted Avg Shares Outstanding (Diluted) | $32.87M | $32.87M | $33.006M | $33.006M |
Over the last four quarters, Mandarake Inc.'s revenue moved from $3.68B in Q2 2024 to $3.76B in Q1 2025. Operating income in Q1 2025 was $320.30M, with a strong operating margin of 9%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Mandarake Inc. remained robust at $375.32M, reflecting operational efficiency. Net income dropped to $145.45M, with an EPS of $4.42. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan